Ver registro no DEDALUS
Exportar registro bibliográfico

Metrics


Metrics:

4-Chloro-3-nitro-N-butylbenzenesulfonamide acts on KV3.1 channels by an open-channel blocker mechanism (2017)

  • Authors:
  • USP affiliated authors: VARANDA, WAMBERTO ANTONIO - FMRP
  • USP Schools: FMRP
  • DOI: 10.1007/s00726-017-2488-0
  • Subjects: AMINOÁCIDOS; CANAIS DE POTÁSSIO; FIBROBLASTOS
  • Keywords: KV3.1; N-alkylbenzenesulfonamides; Open-channel blockers; Patch-clamp
  • Agências de fomento:
  • Language: Inglês
  • Imprenta:
    • Publisher place: Wien
    • Date published: 2017
  • Source:
    • Título do periódico: Amino Acids
    • ISSN: 0939-4451
    • Volume/Número/Paginação/Ano: v. 49, n. 11, p. 1895-1906, 2017
  • Acesso online ao documento

    Online accessDOI or search this record in
    Informações sobre o DOI: 10.1007/s00726-017-2488-0 (Fonte: oaDOI API)
    • Este periódico é de assinatura
    • Este artigo é de acesso aberto
    • URL de acesso aberto
    • Cor do Acesso Aberto: green

    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      BASSETTO JUNIOR, Carlos Alberto Zanutto; VARANDA, Wamberto Antonio; GONZÁLEZT, Eduardo René Pérez. 4-Chloro-3-nitro-N-butylbenzenesulfonamide acts on KV3.1 channels by an open-channel blocker mechanism. Amino Acids, Wien, v. 49, n. 11, p. 1895-1906, 2017. Disponível em: < http://dx.doi.org/10.1007/s00726-017-2488-0 > DOI: 10.1007/s00726-017-2488-0.
    • APA

      Bassetto Junior, C. A. Z., Varanda, W. A., & Gonzálezt, E. R. P. (2017). 4-Chloro-3-nitro-N-butylbenzenesulfonamide acts on KV3.1 channels by an open-channel blocker mechanism. Amino Acids, 49( 11), 1895-1906. doi:10.1007/s00726-017-2488-0
    • NLM

      Bassetto Junior CAZ, Varanda WA, Gonzálezt ERP. 4-Chloro-3-nitro-N-butylbenzenesulfonamide acts on KV3.1 channels by an open-channel blocker mechanism [Internet]. Amino Acids. 2017 ; 49( 11): 1895-1906.Available from: http://dx.doi.org/10.1007/s00726-017-2488-0
    • Vancouver

      Bassetto Junior CAZ, Varanda WA, Gonzálezt ERP. 4-Chloro-3-nitro-N-butylbenzenesulfonamide acts on KV3.1 channels by an open-channel blocker mechanism [Internet]. Amino Acids. 2017 ; 49( 11): 1895-1906.Available from: http://dx.doi.org/10.1007/s00726-017-2488-0

    Referências citadas na obra
    Aiyar J, Nguyen AN, Chandy KG, Grissmer S (1994) The P-region and S6 of Kv3.1 contribute to the formation of the ion conduction pathway. Biophys J 67:2261–2264
    Armstrong CM (1969) Inactivation of the potassium conductance and related phenomena caused by quaternary ammonium ion injection in squid axons. J Gen Physiol 54:553–575
    Baukrowitz T, Yellen G (1996) Use-dependent blockers and exit rate of the last ion from the multi-ion pore of a K+ channel. Science 271:653–656
    Boddum K, Hougaard C, Xiao-Ying Lin J, von Schoubye NL, Jensen HS, Grunnet M, Jespersen T (2017) Kv3.1/Kv3.2 channel positive modulators enable faster activating kinetics and increase firing frequency in fast-spiking GABAergic interneurons. Neuropharmacology 118:102–112
    Brock MW, Mathes C, Gilly WF (2001) Selective open-channel block of Shaker (Kv1) potassium channels by s-nitrosodithiothreitol (SNDTT). J Gen Physiol 118:113–134
    Cheng YM, Azer J, Niven CM, Mafi P, Allard CR, Qi J, Thouta S, Claydon TW (2011) Molecular determinants of U-type inactivation in Kv2.1 channels. Biophys J 101:651–661
    Choi BH, Choi J-S, Yoon SH, Rhie D-J, Min DS, Jo Y-H, Kim M-S, Hahn SJ (2001) Effects of norfluoxetine, the major metabolite of fluoxetine, on the cloned neuronal potassium channel Kv3.1. Neuropharmacology 41:443–453
    Gan L, Kaczmarek LK (1998) When, where, and how much? Expression of the Kv3.1 potassium channel in high-frequency firing neurons. J Neurobiol 37:69–79
    Grissmer S, Ghanshani S, Dethlefs B, McPherson JD, Wasmuth JJ, Gutman GA, Cahalan MD, Chandy KG (1992) The Shaw-related potassium channel gene, Kv3.1, on human chromosome-11, encodes the type-L K+ channel in T-cells. J Biol Chem 267:20971–20979
    Grissmer S, Nguyen AN, Aiyar J, Hanson DC, Mather RJ, Gutman GA, Karmilowicz MJ, Auperin DD, Chandy KG (1994) Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines. Mol Pharmacol 45:1227–1234
    Gross MF, Beaudoin S, McNaughton-Smith G, Amato GS, Castle NA, Huang C, Zou A, Yu W (2007) Aryl sulfonamido indane inhibitors of the Kv1.5 ion channel. Bioorg Med Chem Lett 17:2849–2853
    Gross MF, Castle NA, Zou A, Wickenden AD, Yu W, Spear KL (2009) Aryl sulfonamido tetralin inhibitors of the Kv1.5 ion channel. Bioorg Med Chem Lett 19:3063–3066
    Hamill OP, Marty A, Neher E, Sakmann B, Sigworth FJ (1981) Improved patch-clamp techniques for high resolution current recording from cells and cell-free membrane patches. Pflugers Arch 391:85–100
    Heginbotham L, Kutluay E (2004) Revisiting voltage-dependent relief of block in ion channels: a mechanism independent of punchthrough. Biophys J 86:3663–3670
    Hille B (2001) Potassium channels and chloride channels. In: Hille B (ed) Ion channels of excitable membranes. Sinauer Associates Inc, Sunderland, pp 131–167
    Ikeda SR, Korn SJ (1995) Influence of permeating ions on potassium channel block by external tetraethylammonium. J Physiol 486:267–272
    Jamieson Q, Jones SW (2013) Role of outer-pore residue Y380 in U-type inactivation of Kv2.1 channels. J Membr Biol 246:633–645
    Kim SE, Ahn HS, Choi BH, Jang H-J, Kim M-J, Rhie D-J, Yoon S-H, Jo Y-H, Kim M-S, Sung K-W, Hahn SJ (2007) Open channel block of A-type, Kv4.3, and delayed rectifier K+ channels, Kv1.3 and Kv3.1, by sibutramine. J Pharmacol Exp Ther 321:753–762
    Klemic KG, Kirsch GE, Jones SW (2001) U-type inactivation of Kv3.1 and Shaker potassium channels. Biophys J 81:814–826
    Kopljar I, Labro AJ, Cuypers E, Johnson HWB, Rainier JD, Tytgat J, Snyders DJ (2009) A polyether biotoxin binding site on the lipid-exposed face of the pore domain of Kv channels revealed by the marine toxin gambierol. Proc Natl Acad Sci USA 106:9896–9901
    Li W, Kaczmarek LK, Perney TM (2001) Localization of two high-threshold potassium channel subunits in the rat central auditory system. J Comp Neurol 437:196–218
    Lien C-C, Jonas P (2003) Kv3 potassium conductance is necessary and kinetically optimized for high-frequency action potential generation in hippocampal interneurons. J Neurosci 23:2058–2068
    Lloyd J, Atwal KS, Finlay HJ, Nyman M, Huynh T, Bhandaru R, Kover A, Schmidt J, Vaccaro W, Conder ML, Jenkins-West T, Levesque P (2007) Benzopyran sulfonamides as Kv1.5 potassium channel blockers. Bioorg Med Chem Lett 17:3271–3275
    Martins CC, Bassetto CAZ, Santos JM, Eberlin MN, Magalhães A, Varanda WA, Gonzalez ERP (2016) Mass spectrometry study of N-alkylbenzenesulfonamides with potential antagonist activity to potassium channels. Amino Acids 48:445–459
    McCrossan ZA, Lewis A, Panaghie G, Jordan PN, Christini DJ, Lerner DJ, Abbott GW (2003) MinK-related peptide 2 modulates Kv2.1 and Kv3.1 potassium channels in mammalian brain. J Neurosci 23:8077–8091
    Olsson RI, Jacobson I, Iliefski T, Boström J, Davidsson Ö, Fjellström O, Björe A, Olsson C, Sundell J, Gran U, Gyll J, Malmberg J, Hidestål O, Emtenäs H, Svensson T, Yuan Z-Q, Strandlund G, Åstrand A, Lindhardt E, Linhardt G, Forsström E, Högberg Å, Persson F, Andersson B, Rönnborg A, Löfberg B (2014) Lactam sulfonamides as potent inhibitors of the Kv1.5 potassium ion channel. Bioorg Med Chem Lett 24:1269–1273
    Ousingsawat J, Spitzner M, Puntheeranurak S, Terracciano L, Tornillo L, Bubendorf L, Kunzelmann K, Schreiber R (2007) Expression of voltage-gated potassium channels in human and mouse colonic carcinoma. Clin Cancer Res 13:824–831
    Rodrigues ARA, Arantes EC, Monje F, Stühmer W, Varanda WA (2003) Tityustoxin-K(alpha) blockade of the voltage-gated potassium channel Kv1.3. Br J Pharmacol 139:1180–1186
    Rudy B, McBain CJ (2001) Kv3 channels: voltage-gated K+ channels designed for high frequency repetitive firing. Trends Neurosci 24:517–526
    Shieh C-C, Coghlan M, Sullivan JP, Gopalakrishnan M (2000) Potassium channels: molecular defects, diseases, and therapeutic opportunities. Pharmacol Rev 52:557–593
    Sung MJ, Ahn HS, Hahn SJ, Choi BH (2008) Open channel block of Kv3.1 currents by fluoxetine. J Pharmacol Sci 106:38–45
    Supuran CT, Scozzafava A, Jurca BC, Ilies MA (1998) Carbonic anhydrase inhibitors—part 49: synthesis of substituted ureido and thioureido derivatives of aromatic/heterocyclic sulfonamides with increased affinities for isozyme I. Eur J Med Chem 33:83–93
    Taskin B, von Schoubye NL, Sheykhzade M, Bastlund JF, Grunnet M, Jespersen T (2015) Biophysical characterization of Kv3.1 potassium channel activating compounds. Eur J Pharmacol 758:164–170
    Wang L-Y, Gan L, Forsythe ID, Kaczmarek LK (1998) Contribution of the Kv3.1 potassium channel to high-frequency firing in mouse auditory neurones. J Physiol 509:183–194
    Yasuda T, Cuny H, Adams DJ (2013) Kv3.1 channels stimulate adult neural precursor cell proliferation and neuronal differentiation. J Physiol 591:2579–2591